Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.

by Cristina Cigana, Laura Curcurù, Maria Rosaria Leone, Teresa Ieranò, Nicola Ivan Lorè, Irene Bianconi, Alba Silipo, Flora Cozzolino, Rosa Lanzetta, Antonio Molinaro, Maria Lina Bernardini, Alessandra Bragonzi
Published 2009-12-01